John Menditto | executive |
David Mazzo | executive |
James Nisco | executive |
Kristen Buck | executive |
Sara Nik | analyst |
Will Hidell | analyst |
Peter Enderlin | analyst |
Stephen Brozak | analyst |
Robert Sassoon | analyst |
Robert LeBoyer | analyst |
Welcome to the Lisata Therapeutics First Quarter 2024 Financial Results and Business Update Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to our first speaker today, John Menditto, Vice President of Investor Relations and Corporate Communications. Please go ahead.
Thank you, operator, and good afternoon, everyone.